5 completed, 3 terminated, 3 unknown. 11 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 11 | Completed 5, Terminated 3, Unknown 3 |
Follow pegaptanib: new trials by email Literature Review of pegaptanib trials Research Report on pegaptanib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cohort Study of the Clinical Course of Macular Diseases in Kagawa ranibizumab, aflibercept, pegaptanib, verteporphin - Macular Disease | Phase 4 | Unknown | Kagawa University | 1000 | 2014-12-01 | 2018-03-07 |
| Intravitreal Macugen for Ischaemic Diabetic Macular Oedema Intravitreal injection of pegaptanib sodium - Diabetic Macular Oedema | Phase 4 | Completed | University of Oxford | 30 | 2011-01-01 | 2014-12-24 |
| Extension Study to Gather Data on Effect of Macugen on the Corneal Endothelium pegaptanib sodium injection - Age-Related Macular Degeneration, Retinal Vein Occlusion | Phase 4 | Completed | Bausch & Lomb Incorporated | 131 | 2010-04-22 | 2021-01-08 |
| Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study Macugen® pegaptanib sodium - Diabetic Macular Edema | Phase 4 | Completed | Valley Retina Institute | 72 | 2009-04-01 | 2013-07-16 |
| Macugen for Proliferative Diabetic Retinopathy Study With Extended Dosing (M-PDRS ED) Macugen ® (pegaptanib sodium) - Proliferative Diabetic Retinopathy | Phase 4 | Unknown | Valley Retina Institute | 30 | 2007-11-01 | 2011-12-06 |
| An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD Pegaptanib Sodium 0.3 mg - Age Related Macular Degeneration (AMD), Macular Degeneration | Phase 4 | Terminated | Pfizer | 288 | 2006-07-01 | 2012-04-04 |
| Evaluation Of Safety And Efficacy Of 0.3 Mg/Eye Macugen In Patients With Small Age-Related Macular Degeneration Lesions pegaptanib sodium (Macugen) - Macular Degeneration | Phase 4 | Completed | Pfizer | 81 | 2006-07-01 | 2010-03-23 |
| A Clinical Trial to Explore the Safety and Efficacy of Injections of Macugen When Given Every 6 Weeks in Subjects With AMD pegaptanib sodium (Macugen) - Age-Related Macular Degeneration (AMD) | Phase 4 | Unknown | Eyetech Pharmaceuticals | 1000 | 2006-06-01 | 2007-01-15 |
| A Clinical Trial to Explore the Safety and Efficacy of Three Different Doses of Pegaptanib Sodium in Patients With Wet Age-Related Macular Degeneration (AMD) Pegaptanib sodium - Macular Degeneration | Phase 4 | Terminated | Eyetech Pharmaceuticals | 262 | 2006-04-01 | 2007-01-15 |
| Evaluation of Macugen Treatment of Macular Edema Due to Branch Retinal Vein Occlusion pegaptanib sodium (Macugen) - Branch Retinal Vein Occlusion | Phase 4 | Completed | Palmetto Retina Center, LLC | 20 | 2006-01-01 | 2014-09-12 |
| Macugen (Pegaptanib Sodium) Alone, Versus Macugen in Combination With PDT (Photodynamic Therapy) With Visudyne (Verteporfin) in Patients With Age-Related Macular Degeneration (AMD) Photodynamic Therapy (PDT) with Visudyne (verteporfin), Macugen (pegaptanib sodium) - Age-Related Macular Degeneration | Phase 4 | Terminated | Eyetech Pharmaceuticals | 360 | 2005-03-01 | 2007-01-15 |
Macular Degeneration (7) · Retinal Vein Occlusion (2) · Choroidal Neovascularization (1) · Ischemia (1) · Macular Edema (1)
Eyetech Pharmaceuticals (3) · Pfizer (2) · Valley Retina Institute (2) · Bausch & Lomb Incorporated (1) · Kagawa University (1) · Palmetto Retina Center, LLC (1) · University of Oxford (1)
United States (7) · France (2) · United Kingdom (2) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · Germany (1) · Greece (1) · Italy (1) · Japan (1) · Poland (1) · Portugal (1)
Akiataka Tsujikawa, MD (1) · John A Wells, III, MD (1) · Mandeep Kaur, M.D. (1) · Victor Chong, MPhil, MD, FRCSEd, FRCOphth (1) · Victor Gonzalez, Dr. (1) · Victor H. Gonzalez, MD (1)